TNDM · Tandem Diabetes Care, Inc.
$17.43
+1.63% last session
End-of-day data · close of 2026-10-23
Market cap
$1B
Enterprise value
$1B
Trailing P/E
—
Forward P/E
109.7
Dividend yield
0.0%
Beta
1.66
Avg volume
2M
Employees
2K
Daily Change %
1.63%
5 Days Change
6.41%
10 Days Change
8.87%
30 Days Change
14.52%
60 Days Change
-19.23%
Month to Day Change
5.64%
Year to Day Change
-20.70%
Analyst Outlook
Analyst estimates change daily — follow the shifts on the Estimate Trends page.
Technical Analysis
Analyst sentiment over time — TNDM
Rec Mean (blue, left — higher = more bullish) vs. price targets (right).
Investment Bank Ratings as of 2026-10-07
Latest call per bank · past 12 months
Barclays
Equal-Weight$18.00
+3.3% vs priceCitigroup
Neutral$20.00
+14.7% vs priceRBC Capital
Outperform$26.00
+49.2% vs priceDeutsche Bank
Hold$15.50
-11.1% vs priceWells Fargo
Overweight$27.00
+54.9% vs priceBank of America
Neutral$25.00
+43.4% vs priceGoldman Sachs
Neutral$25.00
+43.4% vs priceMorgan Stanley
Equal-Weight$25.00
+43.4% vs priceUBS
Neutral$22.00
+26.2% vs priceRecent rating actions
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-10-07 | Barclays | Initiates | Equal-Weight | $0.00 → $18.00 |
| 2026-09-30 | Citigroup | Maintains | Neutral | $24.00 → $20.00 |
| 2026-09-24 | Truist Securities | Maintains | Buy | $31.00 → $28.00 |
| 2026-08-21 | William Blair | Initiates | Outperform | $0.00 |
| 2026-08-07 | Citigroup | Maintains | Neutral | $17.00 → $21.00 |
| 2026-08-07 | RBC Capital | Maintains | Outperform | $30.00 → $26.00 |
| 2026-07-15 | Mizuho | Maintains | Neutral | $24.00 → $20.00 |
| 2026-06-23 | Deutsche Bank | Initiates | Buy → Hold | $0.00 → $15.50 |
Ratings and price targets are the published opinions of the issuing banks, compiled from Yahoo Finance rating actions — not investment advice.
Signal Summary as of 2026-10-23
- neutral: RSI (14): RSI is 55 — neutral momentum, neither overbought nor oversold.
- bearish: Price vs 50-day MA: Trading 5.2% below the 50-day MA ($18.38).
- bearish: Price vs 200-day MA: Trading 8.2% below the 200-day MA ($18.99).
- bearish: MA cross: The 50-day MA sits below the 200-day MA (death-cross regime) — the longer-term trend points down.
- bullish: MACD (12,26,9): MACD histogram is positive (+0.25) — short-term momentum is improving.
- neutral: 52-week range: Price sits between the 52-week low ($12.82) and high ($28.26).
TNDM Price Chart
Loading chart for TNDM…
Fundamentals
About Tandem Diabetes Care, Inc.
Tandem Diabetes Care, Inc. designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. It's flagship products are the t:slim X2 insulin delivery system; and Tandem Mobi insulin pump, an automated insulin delivery system. The company also sells single-use products, including cartridges for storing and delivering insulin, and infusion sets that connect the insulin pump to the user's body. In addition, it offers Tandem Device Updater used to update the pump software from a personal computer; Tandem Source, a web-based data management platform, which provides a visual way to display diabetes therapy management data from the pumps, integrated CGMs; and Sugarmate, a mobile app used to help people visualize diabetes therapy data. The company has collaboration agreement with the University of Virginia Center for Diabetes Technology for research and development of fully automated closed-loop insulin delivery systems. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.
More in Medical Devices
ABT
Abbott Laboratories
$179B -16.2% YTD
MDT
Medtronic plc.
$122B 3.1% YTD
SYK
Stryker Corporation
$118B -11.9% YTD
BSX
Boston Scientific Corporation
$66B -51.7% YTD
EW
Edwards Lifesciences Corporatio
$51B 5.7% YTD
GEHC
GE HealthCare Technologies Inc.
$33B -12.8% YTD
DXCM
DexCom, Inc.
$29B 18.0% YTD
PHG
Koninklijke Philips N.V. NY Reg
$26B 3.3% YTD
Data is sourced from end-of-day snapshots and refreshed daily before the US market open — nothing on this page is real-time. Figures can contain vendor errors. This page is for information only and is not investment advice.